These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2732232)

  • 1. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction.
    Jordan RE; Nelson RM; Kilpatrick J; Newgren JO; Esmon PC; Fournel MA
    J Biol Chem; 1989 Jun; 264(18):10493-500. PubMed ID: 2732232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin inactivation by neutrophil elastase requires heparin.
    Jordan RE; Nelson RM; Kilpatrick J; Newgren JO; Esmon PC; Fournel MA
    Am J Med; 1989 Sep; 87(3B):19S-22S. PubMed ID: 2801725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin promotes the inactivation of antithrombin by neutrophil elastase.
    Jordan RE; Kilpatrick J; Nelson RM
    Science; 1987 Aug; 237(4816):777-9. PubMed ID: 3649921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.
    Craig PA; Olson ST; Shore JD
    J Biol Chem; 1989 Apr; 264(10):5452-61. PubMed ID: 2925612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of heparin cofactor II with neutrophil elastase and cathepsin G.
    Pratt CW; Tobin RB; Church FC
    J Biol Chem; 1990 Apr; 265(11):6092-7. PubMed ID: 2318847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P1 variant antithrombins Glasgow (393 Arg to His) and Pescara (393 Arg to Pro) have increased heparin affinity and are resistant to catalytic cleavage by elastase. Implications for the heparin activation mechanism.
    Owen MC; George PM; Lane DA; Boswell DR
    FEBS Lett; 1991 Mar; 280(2):216-20. PubMed ID: 2013315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disulfide bond in antithrombin is required for heparin-accelerated thrombin inactivation.
    Longas MO; Ferguson WS; Finlay TH
    J Biol Chem; 1980 Apr; 255(8):3436-41. PubMed ID: 7364749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for proteolytically inactivated antithrombin-III: use of sodium dodecyl sulfate to eliminate signal due to intact antithrombin-III.
    Esmon PC; Yee E
    Anal Biochem; 1992 May; 202(2):344-7. PubMed ID: 1519763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin.
    Björk I; Nordenman B
    Eur J Biochem; 1976 Sep; 68(2):507-11. PubMed ID: 976270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of factor XIa by antithrombin III.
    Soons H; Janssen-Claessen T; Tans G; Hemker HC
    Biochemistry; 1987 Jul; 26(15):4624-9. PubMed ID: 3499176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
    Danielsson A; Raub E; Lindahl U; Björk I
    J Biol Chem; 1986 Nov; 261(33):15467-73. PubMed ID: 3782075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin interferes with the inhibition of neutrophil elastase by its physiological inhibitors.
    Faller B; Frommherz K; Bieth JG
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):503-8. PubMed ID: 1515082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K; Komorowicz E; Machovich R
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):905-11. PubMed ID: 7534486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.